February 12, 2018 / 12:18 PM / 10 months ago

BRIEF-Horizon Discovery Enters into An Agreement With A Immuno-Oncology Therapeutics Developer​

Feb 12 (Reuters) - Horizon Discovery Group Plc:

* HORIZON DISCOVERY GROUP PLC - ‍ENTERED INTO A NON-EXCLUSIVE OUT-LICENSING AGREEMENT WITH A US-BASED IMMUNO-ONCOLOGY THERAPEUTICS DEVELOPER​

* HORIZON DISCOVERY -DEAL FOR CO’S PROPRIETARY TECHNOLOGIES TO SUPPORT DEVELOPMENT,MANUFACTURE OF NOVEL BIOMANUFACTURING CELL LINE FOR COMMERCIAL USE​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below